In the context of an active virus infection, HMGB1 bound to viral nucleic acids could act as an adjuvant that ultimately exacerbates inflammatory responses thereby promoting cell death, immunity, and sensitization to antineoplastic drugs. This evidence concerns the gene HMGB1 and viral infectious disease.